Amyris Inc. (AMRS)
Company Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America.
The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets.
It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names.
The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine.
The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010.
Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
| Country | United States |
| IPO Date | Sep 28, 2010 |
| Industry | Chemicals - Specialty |
| Sector | Basic Materials |
| Employees | 1,598 |
| CEO | Hermanus Kieftenbeld |
Contact Details
Address: 5885 Hollis Street EmeryVille, California United States | |
| Website | https://amyris.com |
Stock Details
| Ticker Symbol | AMRS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001365916 |
| CUSIP Number | 03236M200 |
| ISIN Number | US03236M2008 |
| Employer ID | 55-0856151 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Hermanus Kieftenbeld | Interim Chief Executive Officer, Chief Financial Officer & Chief Admin. Officer |
| John G. Melo | Pres, Chief Executive Officer & Director |
| Christine Ofori | Chief People Officer |
| Eduardo Alvarez | Chief Operating Officer |
| Nicole Kelsey | Chief Legal Officer & Sec. |
| Annie Tsong | Chief Product & Technology Strategy Officer |
| Beth Baker Bannerman | Chief Engagement & Sustainability Officer |
| Caroline Hadfield | Pres of Aprinnova |
| Charles Kraft | Senior Vice President of Global Manufacturing & Process Devel. |
| Daya Fields | Pres of Pipette & Purecane |
| Doris Choi | Gen. Counsel & Sec. |
| Elizabeth E. Dreyer CPA | Chief Accounting Officer & Corporation Controller |
| Jim Iacoponi | Senior Vice President of Nutrition Ingredients |
| Peter DeNardo | Senior Director of Investor Relations & Corporation Communications |
| Sunil Chandran | Chief Science Officer and Head of R&D |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | 4 | Filing |
| May 07, 2024 | SC 13D/A | [Amend] Filing |